This HTML5 document contains 52 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n21http://linked.opendata.cz/ontology/domain/vavai/riv/statVydaniPatentuVzoru/
dctermshttp://purl.org/dc/terms/
n17http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n13http://linked.opendata.cz/resource/domain/vavai/subjekt/
n8http://linked.opendata.cz/ontology/domain/vavai/riv/uzemniOchranaPatentu/
n12http://linked.opendata.cz/ontology/domain/vavai/
n18http://linked.opendata.cz/resource/domain/vavai/zamer/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/vyuzitiPatentuVzoru/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/licencniPoplatek/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61389030%3A_____%2F13%3A00425883%21RIV14-AV0-61389030/
n7http://linked.opendata.cz/ontology/domain/vavai/riv/vyuzitiJinymSubjektem/
n4http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n19http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n14http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n22http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n11http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n5http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61389030%3A_____%2F13%3A00425883%21RIV14-AV0-61389030
rdf:type
n12:Vysledek skos:Concept
rdfs:seeAlso
http://www.allindianpatents.com/patents/256069
dcterms:description
The present invention is related to 3-, 5-, 7-trisubstituted pyrazolo[4,3-d]pyrimidines represented by the general formula I and pharmaceutically acceptable salts thereof. The present invention is related to 3-, 5-, 7-trisubstituted pyrazolo[4,3-d]pyrimidines represented by the general formula I and pharmaceutically acceptable salts thereof.
dcterms:title
Novel pyrazolo (4,3-D)pyrimidines, processes for their preparation and methods for therapy Novel pyrazolo (4,3-D)pyrimidines, processes for their preparation and methods for therapy
skos:prefLabel
Novel pyrazolo (4,3-D)pyrimidines, processes for their preparation and methods for therapy Novel pyrazolo (4,3-D)pyrimidines, processes for their preparation and methods for therapy
skos:notation
RIV/61389030:_____/13:00425883!RIV14-AV0-61389030
n12:predkladatel
n13:ico%3A61389030
n3:aktivita
n14:Z
n3:aktivity
Z(AV0Z50380511)
n3:cisloPatentuVzoru
IN256069
n3:datumUdeleniPatentuVzoru
2013-04-29+02:00
n3:dodaniDat
n5:2014
n3:domaciTvurceVysledku
n17:1870378 n17:9130241 n17:4712048 n17:9896821 n17:9961216
n3:druhVysledku
n11:P
n3:duvernostUdaju
n9:S
n3:entitaPredkladatele
n10:predkladatel
n3:idSjednocenehoVysledku
92378
n3:idVysledku
RIV/61389030:_____/13:00425883
n3:jazykVysledku
n19:eng
n3:klicovaSlova
therapeutic methods; cell cycle; pyrazolo[4,3-d]pynmidine derivatives
n3:klicoveSlovo
n4:therapeutic%20methods n4:cell%20cycle n4:pyrazolo%5B4 n4:3-d%5Dpynmidine%20derivatives
n3:kontrolniKodProRIV
[49DC30890019]
n3:licencniPoplatek
n16:A
n3:mistoVydaniPatentuVzoru
Mumbai
n3:nazevVydavatelePatentuVzoru
Office of the Controller-General of Patents, Designs and Trademarks
n3:obor
n22:CE
n3:pocetDomacichTvurcuVysledku
5
n3:pocetTvurcuVysledku
5
n3:rokUplatneniVysledku
n5:2013
n3:statVydaniPatentuVzoru
n21:IN
n3:tvurceVysledku
Havlíček, Libor Kryštof, Vladimír Lenobel, René Moravcová, Daniela Strnad, Miroslav
n3:uzemniOchranaPatentu
n8:D
n3:vlastnik
n10:vlastnikVysledku
n3:vyuzitiJinymSubjektem
n7:A
n3:vyuzitiPatentuVzoru
n15:B
n3:zamer
n18:AV0Z50380511
n3:vlastnikPatentuVzoru
Ústav experimentální botaniky AV ČR, v. v. i